Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques-Reference-Cited by-同舟云学术

Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques

Published:2023-01-12 Issue:7 Volume:135 Page:
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angewandte Chemie

Author:

Lee Hee Yang¹,Baek Seungyeop¹,Cha Minhae¹,Yang Seung‐Hoon²,Cho Illhwan¹,Shin Heewon¹,Lee Sejin¹,Kim Hye Yun¹,Lee Songmin¹,Shin Jisu¹,Lee Donghee¹,Kim Kyeonghwan¹,Park InWook¹,Yoon Soljee¹³,Kim Jiyoon⁴,Park Seong Jeong⁵,Kim Seong Muk⁵,Kim Ko Eun⁵,Kim Hye Ju⁵,Oh Min‐Seok⁶⁷,Lee Gwan‐Ho⁶,Yu Byung‐Yong⁶,Kannan Priyadharshini⁸⁹,Park Keunwan⁹,Kim YoungSoo¹³⁵^ORCID

Affiliation:

1. Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea

2. Department of Medical Biotechnology Dongguk University Jung-gu Seoul 04620 South Korea

3. Department of Integrative Biotechnology and Translational Medicine Yonsei University Yeonsu-gu Incheon 21983 South Korea

4. Brain Science Institute Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea

5. Amyloid Solution Bundang-gu Seongnam-si Gyeonggi-do 13486 South Korea

6. Advanced Analysis and data Center Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea

7. Department of Stem Cell Biology Konkuk University Gwangjin-Gu Seoul 05029 South Korea

8. Department of Biochemical Engineering Gangneung-Wonju National University Gangneung 25457 South Korea

9. Natural Product Informatics Research Center Korea Institute of Science and Technology Gangwon-do 25451 South Korea

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Korea Institute of Science and Technology

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.202210209

Reference25 articles.

1. Protein aggregation and neurodegenerative disease

2. Amyloid beta: structure, biology and structure-based therapeutic development

3. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

4. Amyloid fibril polymorphism: a challenge for molecular imaging and therapy

5. Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery